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Summary
The potential ofcells within the central nervous system (CNS) to initiateT lymphocyte responses
is not known and was the subject of this study. Using the ability of virgin T lymphocytes to
proliferate in a primary response to allogeneic determinants on antigen-presenting cells (APC),
we have examined the capacity of major histocompatibility complex (MHC)-expressing astroglial
cells to act as stimulators of primary and secondary T cell responses . Neither freshly isolated
astrocytes nor primary astrocyte cultures pretreated with interferony (IFN-y) to upregulateMHC
class I and II expression stimulated unfractionatedlymph node (LN) cell populations in the primary
mixed lymphocyte reaction . In mixing experiments, astrocyyes did not inhibit theT cell response
to allogeneic LN stimulators . Purified responder CD4+ T cells also were not stimulated to
proliferate or secrete interleukin 2 (Ilr2) byMHC class I- and II-expressing astrocyyes. In contrast
to their inability to stimulate virgin, alloreactive CD4+ T cells, astrocyyes were able to speci-
fically stimulate an alloreactive CD4+ T cell line . Unprimed CD8+ T cells, however, exhibited
some weak autonomous proliferation to astrocyte stimulators but this response was only substantial
in the presence of exogenous IIr2, the latter predominantly being a CD4+ T cell product . Those
CD8+ T cells responding in the presence of IIr2 were mainly T cell receptor a/a+ IIr2 receptor
(cx chain)', and a majority had shifted from high to low CD45R expression. Given the virtual
dependence of CD8+ T cells in these studies, on CD4+ T cell help, and the complete absence
of activation of this latter subset by astrocyyes, it is clear that in the context of this resident
CNS cell, further activation of either T cell subset by astrocytes within the CNS can only follow
priming by another type ofAPC . The implications of these results for the induction of T cell
responses in the CNS are discussed .
T
he site of initiation of central nervous system (CNS) 1
auto-immune inflammatory diseases is generally un-
known, except of course under those laboratory conditions
such as in experimental autoimmune encephalomyelitis (EAE),
where CD4+ T cells with specificity for CNS autoantigens
are generated by peripheral immunization (1) . However, spon-
taneously arising CNS inflammatory diseases with a suspected
autoimmune base such as multiple sclerosis (MS) could con-
ceivably be initiated in the CNS itself or alternatively could
' Abbreviations used in this paper: AST, astrocytes ; CNS, central nervous
system ; DC, dendritic cells ; EAE, experimental autoimmune encephalo-
myelitis ; GaIC, galactocerebroside ; GFAP, glial fibrillary acidic protein;
LEW, Lewis; MS, multiple sclerosis.
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be a consequence of peripheral autoreactive T cell stimula-
tion. Evidence for thesetwo opposing views has recently been
reviewed (2, 3) .
To begin to understand the induction ofthese types ofCNS
inflammatory diseases one must first consider the set ofunique
anatomical and immunological circumstances present (reviewed
in reference 4). Foremost among these is the virtual absence
of cells, either resident or ofbonemarrow origin, expressing
MHC class I or class II molecules which are the prerequisite
elements for presentation of antigenic peptides to CD8+ and
CD4+ T lymphocytes, respectively (reviewed in reference 5) .
Under these conditions it is difficult to envisagehow an inflam-
matory reaction can be initiated . It is known, however, that
products of activated T lymphocytes such as IFN-y can in-
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ments like astrocytes (AST ; reference 6) and microglia (7) but
one could then argue that theMHC induction observed on
these cells in diseases like MS (8, 9) is an event secondary
to the activation of the IFN-y-secreting T cell so the resi-
dent CNS elements could not have initiated the response .
Within this framework, however, it is nevertheless feasible
that once glial cells are induced to expressMHC antigens,
essentially as bystander cells of, for example, CNS inflamma-
tion after a viral or bacterial infection, these glial cells would
have the capacity to play an active role in presentation of self
antigens to T cells that are then present within the CNS .
Indeed it has been previously demonstrated (10-12) that the
bulk ofT cells present in aCNS inflammatory infiltrate ac-
cumulate nonspecifically subsequent to damage mediated by
a small number of specific effector T cells and it is possible
that at least some of these inflammatoryT lymphocytes may
be (auto)reactive for CNS antigens. Another related way in
which CNS autoimmune inflammatory disease may be precipi-
tated is after direct MHC induction on glial cells mediated
by viral particles via an IFN-y-independent mechanism (13) .
An important consideration, however, is whether glial cells,
once induced to expressMHC antigens (by whatever mecha-
nism), can then initiate T cell responses or if they merely
perpetuate a response that has been initiated elsewhere, that
is, outside theCNS, and by another cell type. Primarily using
theMLR as a test system, it has been established that certain
cell types ofbone marrow derivation, most notably dendritic
cells (DC) and activatedB cells (14, 15, reviewed in reference
16), are effective stimulators of primary CD4+ T lympho-
cyte responses while other cell types such as macrophages
and resting B cells efficiently only stimulate CD4+ T cells
once they have been activated (16, 17) . Similarly, unprimed
CD8+ T cells are stimulated by DC in the primary MLR
(18) but, unlike CD4+ T cells, are also reportedly activated
by macrophages and possibly a range of other non-DC APC
(19, 20) . There is no similar definition of the ability ofMHC-
expressing, CNS-resident cells, to stimulate primary and/or
secondary CD4+ and CD8+ T cell responses. The ability
of glial cells to directly participate in the induction of im-
mune responses is obviously relevant to potential mechanisms
of autoreactive T lymphocyte activation .
In this report we examine the potential of a nonhemato-
poietic glial cell, the AST, to stimulate unprimed CD4+ and
CD8 + T lymphocytes in the primary allogeneic MLR . Col-
lectively our results do not provide evidence for a role ofCNS
astroglial cells as initiators ofCD4+ T lymphocyte responses,
while their capacity to stimulate unprimed CD8+ T cells
rests largely on the availability of exogenous 11,2 . However,
the data indicate that AST are potentially important as per-
petuators ofCD4+ T cell responses that have been initiated
after interaction with APC present in peripheral lymphoid
organs.
Materials and Methods
Animals. Full-term pregnant rats, mothers with 7-10-d-old
litters, and 8-10-wk-old female rats were obtained from Zentralin-
stitut for Versuchstierzucht (Hannover, Germany or Moellegard,
Ltd ., Skensved, Denmark) . All animals were Specific Pathogen Free
(SPF) and from the Lewis (LEW, RT1'), PVG (RT1°), and Brown
Norway (BN, RT1a) strains.
Monoclonaland Pol)clonal Antibodies.
￿
MousemAbs were: MRC
OX6 (anti-rat monomorphic MHC class II, RT1B (I-A)), MRC
OX8 (anti-rat CD8),MRC OX12 (anti-rat K chain), MRCOX18
(anti-rat monomorphic MHC class I, RT1A), MRC OX21
(anti-human C3bi and not rat cells), MRC OX22 (anti-rat
CD45R),W3/25 andMRCOX35 (noncompeting anti-rat CD4),
MRC OX39 (anti-rat IIr2R, a chain), MRC OX30 (anti-rat
CD45 ; IXA), MRCOX42 (anti-rat CD11b, C3bi), R73 (anti-rat
a/3 TCR), 1A29 (anti-rat CD54, ICAM-1), 4136 (anti-RAN-2)
and anti-galactocerebroside (GaIC) . See (11, 21-27) for cross refer-
ence details ofmAb . Supernatants ofMRC OX21 andMRCOX39
were provided by Don Mason and Mike Puklavec (MRC Cellular
Immunology Unit, Oxford, U.K .), 1A29 ascites was kindly
provided byM. Miyasaka (Tokyo Metropolitan Institute of Med-
ical Science, Tokyo, Japan) and 4136 supernatant byM . Rag(Univer-
sity College, London, UK) . All other mAb were prepared from
hybridomas obtained from Alan Williams (MRC Cellular Immu-
nology Unit, Oxford,UK.), Thomas Hiinig (Institute for Virology
and Immunobiology, Wurzburg, Germany), (R73 mAb) and B .
Ranscht (Max-Planck Society Laboratories, Tubingen, Germany)
(anti-GaIC mAb) . A rat mAb, R2/15S (28), which binds to a de-
terminant on the polymorphic classical MHC Class I molecule
(RT1.A) and is positive on LEW (RTI.Al) but not on BN
(RT1.A°), was purified from tissue culture supernatants by anti-
rat IgG affinity chromatography, and biotinylated .
Affinity-purified rabbit anti-mouse Ig for coating ofSRBC for
rosetting was prepared by standard immunization and solid-phase
affinity adsorbent procedures. FITC-conjugated donkey or goat
anti-mouse Ig and PE-streptavidin were from Dianova (Hamburg,
Germany) . Rabbit anti-glialfibrillary acidic protein (GFAP) recog-
nizing AST but not other CNS parenchymal cells was from
DAKOPATTS (Hamburg, Germany) .
Astrocyte Preparation
Direct Isolation ofAST .
￿
A method was devised for the isolation
ofAST direct from the CNS of13-16-d-old rats. At this age, both
glial development and GFAP expression in situ are maximal (29) .
We did not succeed in isolating AST directly from newborn or
adult brain . Cerebral lobes were removed from BN or LEW rats,
dissociated through a fine metal sieve, and the mixture subjected
to collagenase andDNAse digestion and fractionated over a multi-
step Percoll gradient as described for microglial cell isolation (J .
Sedgwick, S. Schwender, H . Imrich, R. DSrries, V ter Meulen,
and G . Butcher, manuscript submitted for publication) . Cells re-
covered at a density of 1.065 g/ml consisted of -70% microgha
defined by the mAb MRC OX42 (CD11b/C3bi, reference 30),
3-5% GaIC' cells (oligodendrocytes) and the remainder a heter-
ogeneous population of larger cells, many with a granular appear-
ance. Microglia, Ga1C+ cells and leukocytes were removed by
labeling with mAb against CD11b, CD45, as TCR, rat Ig and
Ga1C and depleting with magnetic beads (see below) to give a popu-
lation of cells enriched forAST (see Results). Recoveries from the
cerebral lobes of four rats was N4 x 106 cells and after Percoll
fractionation and mAb depletion, between 10 and 15% of this
number of cells remained.
Preparation ofCulturedAST and MHC Class II Induction .
￿
Pri-
mary AST cultures were prepared from the meninges-stripped ce-
rebral lobes of 1- to 2-d-old rats as described (31) and grown to
confluence in 270-ml flasks (Falcon, Becton Dickinson, U.S.A .) .
AST were used within a maximum of 21 d of culture establish-
ment but mostly by 14 d when confluence was generally first
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P . H . van der Meide, TNO Primate Center, Rijswijk, The Nether-
lands) was added fresh to some of the AST on each of 4 d before
harvesting of the cells . Routinely, around 95% ofcells were posi-
tive for the AST marker, GFAP . Less than 2% of cells were posi-
tive for eitherLCA (CD45, present on cells ofhematopoietic origin
including microglia, reference 32), MRC OX42 (recognizing rat
microglia and some macrophages, reference 30), or GaIC. Note
that AST recovered from primary culture were also immediately
irradiated and used as stimulator cells so the above data are indica-
tive of AST populations that were present in the MLR studies .
Preparation ofLymphocyte Subpopulations.
￿
Lymphoid cells used
as both stimulators and responders were exclusively derived from
pooled cervical and mesenteric LN . LN cells in the rat generally
respond better in the MLR . than do splenocytes, probably due to
the presence of suppressive macrophages in the latter (33) . Single
cell suspensions ofLN were prepared in cold PBS-0.2% BSA and
used unfractionated (see below), or depleted of various populations
by incubating the cells with a cocktail ofmAb tissue culture super-
natants followed by a rosetting procedure (34) . LEW rat CD4+
T cells were prepared by depletion ofall cells expressingCD8 (MRC
OX8), MHC class II (MRC OX6) and surface Ig (MRC OX12)
in a single rosetting step. LEW CD8* T cells were prepared by
depletion ofcells expressingCD4 (W3/25 andMRC OX35), MHC
class II and surface Ig by rosetting followed by a second purification
using sheep anti-mouse Ig-coated magnetic beads (Dynal A . S.,
Oslo, Norway) to remove residual contaminating cells .
PrimaryMLR .
￿
Responder leukocytes wereunfractionated LN
cells, CD4` or CD8+ T lymphocytes. These were titrated onto
a constant number of2,000 rad (y) irradiated syngeneic or allogeneic
stimulator cells consisting of unfractionated LN cells at 5 x 10 5
per well, fresh AST at 5 x 10' per well, or cultured AST at 2
x 10' per well. This number of cultured AST rapidly adhere to
the well floor and within 24 h form a monolayer. Addition ofhigher
numbers results in cell clumping and retraction oftheAST mono-
layer. Culture vessels were flat-bottomed 96-well plates (A/S Nunc,
Kamstrup, Denmark) . Medium wasRPMI 1640 supplemented with
/3-ME, penicillin, streptomycin, glutamine, sodium pyruvate, and
either5% heat inactivated FCS or 5% normal rat serum (obtained
from 5-6-wk-old male LEW rats) . Results were similar with ei-
ther serum source. Human rIL2 (Cellular Products Inc., Buffalo,
NY) at 2-50 U/ml and W3/25 (anti-rat CD4) IgG at 5 pg/ml
were added to some of the wells . Responder cell proliferation was
assessed by incorporation of ['H]thymidine (0.5 p,Ci/well; Amer-
sham, Braunschweig, Germany) at varying times after culture es-
tablishment (see Results) .
Alloreactive T Cell Line.
￿
A bulk primaryMLR was established
betweenLEW unfractionatedLN responder and irradiatedBNLN
stimulator cells at a ratio of 1:2, respectively, in 270-ml flasks. Be-
tween 4 and 6 d later, blast cells were isolated over a BSA or
metrizoate/Ficoll gradient and aT cell line produced by sequential
rounds ofresting in IL-2 containing media and allogeneic stimulus
with irradiated BN LN cells as described (24) . The phenotype of
this line is detailed in Results . Line cells were recovered after the
fourth and fifth 10-d 11,2 resting phase and proliferation against
LN or AST stimulator cells assessed .
Cytofuorographic Analyses.
￿
Aliquots of 105 to 106 leukocytes or
AST were labeled for 1 h at 4°C with mAb diluted in PBS-0.2%,
BSA-10 mM sodium azide, washed, then incubated at 4°C for 1 h
with FITC-conjugated antibody at 10 pg/ml diluted in PBS-1%,
BSA-10% rat serum-10 mM sodium azide. 10' live gated events
were analyzed on a FACScan® (Becton Dickinson & Co., Heidel-
berg, Germany) .
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11,2 Determinations.
￿
A continuous IL2-dependent mouse CTL
line (designated clone 3, prepared by Thomas Hunig, Wurzburg)
was used to measure the IL2 content ofMLR supernatants. 5 x
103 clone 3 cells were mixed with twofold dilutions of superna-
tants in flat-bottomed 96-well plates and incubated for 20 h then
pulsed for 4 h with 0.5 "Ci [3H]thymidine and proliferation as-
sessed. Supernatant 11,2 content was quantified by relating prolifer-
ation values to a standard curve of human rIL2 to give a units per
milliliter value .
Statistics.
￿
Student's t test was used to compare meancpm scores
ofresponder lymphocytes on syngeneic or allogeneic stimulatorcells.
Results
Direct Isolation ofASTandStimulator Capacity.
￿
Responder
lymphocytes in these studies were predominantly from the
LEW strain, which is not only highly susceptible to the in-
duction of inflammatory CNS reactions (35), but whose T
cells exhibit a substantially greater response that those from
anumber of other rat strains after stimulation by alloantigen
(36) or CNS autoantigens (35) in vitro. Strictly speaking,
the mixture of AST and T cells is not a mixed "leukocyte"
reaction, but for ease, this term will be used to cover such
cell mixtures as well as those that are between two different
populations of leukocytes .
Our first aim was to assess whether freshly isolated and
minimally cultured AST were able to stimulate unprimed
T cells in theMLR and, to this end, a method was devised
to separateAST from the bulk ofother CNS cells (see Materials
and Methods) . Cells isolated from the brain of 13-16-d-old
rats after Percoll density fractionation and depletion of
microglia, oligodendrocytes, and leukocytes were virtually
all large granular cells with high forward and side scatter and
routinely contained <2% of the above cell types as con-
taminants. Around 60% of these cells were weakly GFAP+
as determined by immunofluorescence on cells applied to ad-
herence slides (Superior, Paul Marienfeld KG, Bad Mergen-
theim, Germany) and stained immediately . 25-30% of the
total cells formed a distinct positive population by FACScan
analysis after labeling with the anti-RAN-2 mAb, 4B6, and
a further 20-25% were very weakly positive for this marker.
The expression ofRAN-2 is heterogeneous even on cultured
AST (26) . Collectively, the results indicated that at least60%
of the cells were AST
As expected, there was noMHC expression by these cells
(not shown) but to preinduce these molecules would involve
at least 1-2 d of IFN-'y treatment . To avoid any extension
ofculture time, irradiated syngeneic or allogeneic (BN) AST
were mixed directly with unfractionated LEW LN cells in
the presence ofIFN-y and responder cell proliferation assessed.
Fig. 1 indicates that freshly isolatedBNAST are not stimula-
tory forLEW responderLN cells. The AST nevertheless ap-
pear to induce some degree of nonspecific responder cell
proliferation. Neither the AST in mixing experiments, nor
the presence of IFN-y, inhibit the LN cell response to al-
logeneic LN stimulators (Fig. 1) .
At the end of the 90-h culture in the presence of IFN-y,
all irradiated stimulator AST are weaklyMHC class I+ andFigure 1 .
￿
Inability of freshly isolated astrocytes to stimulate prolifera-
tion of allogeneic lymphocytes. 2 .5 x 105 unfractionated responder LN
cells from LEW rats were mixed with combinations of irradiated LN (5
x 10 5) or freshly isolated AST (5 x 104) stimulator cells in the presence
or absence of 50 U/ml IFN-y . Responder cell proliferation was assessed
after a 90-h incubation time inclusive of an 18-h pulse with [3H]thymi-
dine. Data shown are means of triplicate determinations.
there is a low level expression ofMHC class II (not shown) .
Despite this, no stimulation ofresponder cells was observed .
The inability of these AST to act as stimulators could, at
least in part, be related to the low levelMHC expression which
presumably can only be enhanced by extending the time of
in vitro exposure to IFN-y . We therefore turned to primary
AST cultures which are not only ofhigher purity butwhose
MHC expression can be readily manipulated .
ASTMHC Expression.
￿
AST in situ do not expressMHC
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Figure 2 .
￿
MHC expression ofcultured primary astrocytes . Autofluores-
cence(MRC OX21 mAb, dotted line),MHC Class II (solid line), andMHC
Class I (dashed line) . IFN-y treatment was for 4 d before staining, as de-
scribed in Materials and Methods .
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Figure 3 .
￿
MHC class I- and II-expressing astrocytes do not stimulate
unprimed allogencic lymphocytes . Unfractionated responderLN cells from
LEW (A) or PVG (B) rats were titrated onto syngeneic (open symbols) or
allogeneic (closedsymbols) irradiated stimulator LN cells (A, A), AST (p,
/), or IFN-y treated AST (O, " ) . Allogeneic stimulators were from
BN rats inA andLEW rats in B. Responder cell proliferation was assessed
after a 90-h incubation time inclusive of an 18-h pulse with [3H]thymi-
dine . Data shown are means oftriplicate determinations and are represen-
tative of three separate experiments.
class I and 11, but upregulate MHC class I during growth
in vitro remaining MHC class II negative (Fig. 2, left hand
panels, no IFN--y) . In all three rat strains, the majority of
cells expressed MHC class II after IFN-y treatment as evi-
denced by a shift ofthe whole population to the right . How-
ever, substantial expression was seen in only -55% ofAST
from the LEW strain and35-40% of cells from the BN and
PVG strains . These differences (at least between LEW and
BN) have been reported previously (31) . As a comparison,
-25-30% of the total LEW AST population and 15-20%
ofBN andPVG AST express levels ofMHC class II equiva-
lent to that of normal resting B lymphocytes with a further
5-8% inLEW and BN rats expressingMHC class II levels
similar in intensity to that seen with DC (16) or B blasts
(ourown observations) .MHC class I expression was further
enhanced afterIFN-y treatment but no strain differences were
observed .
RESPONDERS x 10 - 5
Figure 4 .
￿
AST enhance but do not inhibit the T cell response to al-
logeneic LN stimulators. Unfractionated responder LN cells from LEW
rats were titrated onto 5 x 105 LEW syngeneic (open symbols) orBN al-
logeneic (closed symbols) irradiated stimulator LN cells in the presence (" )
or absence (A, A) of 2 x 104 IFN-y pretreated BN AST Addition of
LEW rather thanBN AST gave similar results. Responder cell prolifera-
tion was assessed after a 90-h incubation time inclusive of an 18-h pulse
with [3H]thymidine . Data shown are means oftriplicate determinations .
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Figure 5.
￿
Purity and phenotype ofT cell subsets. CD4* (top row) andCD8+ (bottom row) T cells were isolated from LEW ratLN and immedi-
ately labeled with a variety ofmAb for cytofluorographic analysis. Auto fluorescence in all cases is indicated by the dotted lines using cells stained
with anti-human C3bi mAb, MRC OX21 . (a) dashed line (which overlays the dotted autofluorescence plot) is CD4+ T cells labeled with anti-CD8
mAb and solid line is cells stained with anti-CD4 mAb . (e) dashed line (which overlays the dotted autofluorescence plot) is CD8+ T cells labeled
with anti-CD4mAband solid line is cells stained with anti-CD8 mAb. (b,f ) as TCR . (c, g) IL2R (ct chain) . (d, h) CD45R (MRC OX22 mAb) .
UnfractionatedLN CellsDo Not Respond to Allogeneic AST
Stimulators . Like freshly isolated cells (Fig. 1), allogeneicBN
AST preinduced to expressMHC class II also do not stimu-
late the unprimed T lymphocytes within a mixture of re-
sponder LEW LN cells (Fig . 3 A) . BN LN stimulator cells,
in contrast, induce a substantial and responder cell dose-
dependent response which is reduced by -90% in the pres-
ence of anti-CD4mAb (data not shown) . It should be noted
(Fig. 2) that the percentage of BN AST expressing MHC
class II as well as the level of expression after IFN-,y treat-
ment is generally lower than, for example, theLEW strain .
Possibly theLEW strain is unusual in this respect given that
a third strain (the PVG) was comparable to BN . However,
we also examined the response of PVG LN cell responders
to syngeneic as well as allogeneic (LEW) LN andAST stimu-
lator cells and again, no response to AST was observed (Fig .
3 B) . Thus, the lower levels ofMHC class II expression on
BN AST is probably not the sole reason for the inability of
these cells to stimulate unprimed T lymphocytes.
Fresh AST were not inhibitory in mixing experiments (Fig.
1) . Mixing of cultured AST with LN stimulators (Fig. 4)
resulted in a slight inhibition ofthe response only at the highest
responder cell number (probably a crowding effect) but ap-
peared to have an enhancing effect at the lower responder
cell numbers . Additionally, addition of indomethacin did not
reverse the inability of AST to prime T lymphocytes (data
not shown) .
Weak Autonomous CD8+ But Not CD4+ T Cell Response
to AST Stimulators. Given the heterogenous mixture of re-
sponder cells present in the Fig . 3 experiments, it was feasible
that a positive response from a minority T cell population
may have been overlooked . To examine this possibility, highly
purified LEW responder CD4+ and CD8+ T cells were pre-
pared and tested in the primary MLR against AST stimu-
lator cells .
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As shown in Fig . 5, the purity of thetwo T cell subpopu-
lations was high (N99%) with negligible numbers ofCD8+
T cells in the CD4+ T cell population (Fig . 5 a) or CD4+
T cells in the CD8+ T cell population (Fig. 5 e) . Virtually
all the CD4+ cells were TCRa/a+ (Fig. 5 b) while 10%
of the CD8+ T cells wereTCRa/R- (Fig. 5f) . yS TCR+
cells in the rat have recently been shown to predominantly
lie within this CD8+ TCRa/a- population (37) . Between
5% and 8% ofCD4+ (Fig. 5 c) and <2% ofCD8+ T cells
(Fig. 5g) were IL2R, a chain positive. MRC OX22 (CD45R)
was highly expressed on around two-thirds of CD4+ T cells
(Fig . 5 d) and most (90%) CD8+ T cells (5 h) .
Both in mice and rats (20, 38), CD8+ T cell responses
appear to peak early and then decline. The optimal time to
assess proliferative responses of both CD4+ and CD8+ T
HOURS
CD4+
CD8+
Figure 6.
￿
Early decline of the CD8+ T cell response to allogeneic LN
stimulators . 5 x 10 5 responder CD4+ (") or CD8+ (A,")T cells from
LEW rats were added to the same number ofBN allogeneic irradiated
stimulator LN cells, in the presence (A) or absence (",") of 50 U/ml
rlL2 . Responder cell proliferation was assessed at the timesshownwhich
are inclusive of an 18-h pulse with [3H]thymidine . Data are means of
triplicate determinations and are representative of two comparable ex-
periments .
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.cells was determined in a time course experiment (Fig. 6) .
In response to allogeneic LN stimulator cells, CD8 * T cells
in the presence of IIr2 and CD4+ T cells, responded simi-
larly up to 66 h. After this time, the CD8+ T cell response
leveled off and had declined sharply by 114 h . CD8+ T cells
without IIr2 revealed a low level response with kinetics com-
parable to CD8+ T cells in the presence of IIr2 . The reduc-
tion in the CD4+ T cell response at 114 h probably reflects
cell death or exhaustion of the culturemedium as themedium
at this time was extremely acid. Addition of IL2 to the
CD4+ T cells did not substantially alter their response. A
compromise culture period of 78 h was chosen reflecting a
time o£ peak CD8+ T cell proliferation but also high CD4+
T cell responsiveness .
As with the unfractionated LN responder cells in Fig. 3,
CD4+ T lymphocytes showed no response to AST stimu-
lators (Fig. 7, top three panels) . By microscopic examination
there was, furthermore, no evidence of CD4+ T cell blast
transformation which would, if it occurred, be an indication
that there had been some positive interaction . Anti-CD4mAb
(W3/25) substantially reduced the response of the CD4+T
cells to allogeneic LN stimulator cells as expected and also
blocked the background CD4+ T cell proliferation seen in
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the syngeneic MLR mixture. Comparable data have been
generated in four other similar experiments .
CD8+ T cells did show some, albeit a low level, response
toAST stimulators . In Fig. 7, we have produced results from
three completely separate experiments (A, B, C) which es-
sentially illustrates the difficulty, at least in our hands, of
detecting autonomous primary CD8 + T lymphocyte re-
sponses. Nevertheless, the responses are real and significant
and could no be blocked by anti-CD4 mAb. Even with LN
stimulators cells (left hand panels), allogeneic CD8+ T cell
responses were at best (experiment B), 7-10 times higher than
background and usually only two to five times greater but
with a magnitude some 20-40 times less than the equivalent
number ofCD4+ T cells. After IFN-y treatment, allogeneic
(BN) AST were more consistent stimulators for CD8+ T
cells but the response was of low magnitude and the titra-
tion curves rather flat . Addition of higher numbers of
CD8+ responder cells (106) usually resulted in a lower re-
sponse than with 5 x 105 responder cells and extension of
the incubation time was also detrimental to the magnitude
of the response (not shown) .
11,2 Production by CD4+ and CD8+ T Cells. LEW
CD4* or CD8+ T cells were cultured in the presence of ir-
10
0 .01
0.63 5 2.5 1 .25 0.63
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Figure 7 .
￿
Weak autonomous CD8+, but not CD4+ T cell proliferation in response to allogeneic astrocyte stimulator cells. Responder LEW rat
CD4* andCD8+ T cells were titrated onto constant numbers of irradiated BN orLEW stimulator cells as described in Fig. 3 . Purified W3/25 IgG
(anti-ratCD4mAb) was added to some of the wells at a final concentration of 5 ug/ml. The incubation time was 60-h + 18-h [3H]thymidine pulse .
Data shown are means of triplicate determinations . Three separate experiments (A, B, and C) are illustrated . The key in the top boxes refers to the
stimulator cells and is also consistent for thetwo underlying graphs. Note the logarithmic scale difference between CD4+ T cell responders (105 cpm)
and CD8+ T cell responders (104 cpm) . *Proliferation ofT cells with allogeneic stimulators is significantly greater (p < 0.05) than when mixed with
syngeneic stimulator cells. For CD8+ T cells, data from wells both with and without anti-CD4 mAb are combined for statistical analysis .Table 1.
￿
MHC Class II-expressing AST Do Not Stimulate IL-2 Production by CD4+ T Cells
5 x 105 LEW CD4+ or CD8+ T cells were cultured together with irradiated stimulator cells, and supernatants were collected at the times shown
and tested for IL-2 content . Proliferation of T cells in parallel cultures was determined at 78 h inclusive of an 18-h f3H]thymidine pulse (mean cpm
of triplicate wells) .
" Means ± 1 SD of supernatants from triplicate wells (U/ml) .
t No proliferation of indicator cells above background.
11 Proliferation of T cells is significantly different to the syngeneic control (p<0.001) .
I In this experiment, no significant CD8+ T cell proliferation against AST stimulators was observed (p>0 .1) .
radiated syngeneic or allogeneicLN and IFN-y-treatedAST
stimulator cells and supernatants collected and tested forT
cell growth factor (I1,2) content (Table 1) . 11,2 was detected
only in wells containingLEWCD4+ T cells and allogeneic
(BN) LN stimulator cells. CD8+ T cells proliferated in re-
sponse to BN LN stimulators but no 11,2 was detectable .
In this experiment, no CD8+ T cell proliferation above
background was detected when cultured together with BN-
IFN-y-treated AST
AST as Stimulators of Primary CD8+ T Cell Responses
in the Presence ofIL2 . Table 2 illustrates the response by
CD8+ T cells following addition ofrI1T2 which resulted in
IL-2 in culture supernatants
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levels of proliferation many times greater than that seen in
the absence of I1,2 . A number of features of this response
are noteworthy. First, in every experimentwe have conducted,
the CD8+ T cell response in the presence of AST stimu-
lators is at least four to five times greater than that seen with
LN stimulators . Second, there is no requirement for further
ASTMHC Class Iupregulation (bytreatment with IFN-'y)
to elicit a strong CD8+ T cell proliferation although such
treatment of the AST is clearly beneficial to the magnitude
of the CD8+ T cell response. Third, the specificity, that is
the relative responsiveness to syngeneic vs . allogeneic stimu-
lators, of theCD8+ T cell response in the presence of I1,2
1.25 x 10 5 LEW CD4+ or CD8+ cells were cultured together with irradiated stimulator cells in the presence or absence of rIL-2 for 78 h inclusive
of an 18-h VH]thymidine pulse . Data shown are mean cpm of triplicate determinations . NS; no statistically significant difference in theT cell response
between syngeneic (LEW) and allogeneic (BN) stimulator cells .
CD8+ T cells in the presence of IL-2 but in the absence of any stimulator cells exhibited proliferation indices similar to that seen when syngeneic
LN cells were added .
Stimulator cells
24
CD4+
h
CD8+
48 h
CD4+ CD8'
72 h
CD4+ CD8+
T
proliferation
CD4+
lymphocyte
CD8+
BN LN - - 35 ± 10' _s 750 ± 300 - 43,1709 2,8359
LEW LN - - - - - 302 234
BN IFN yAST - - - - - 520 5881
LEW IFN yAST - - - - - 612 458
Table 2. No CD4+ but Strong Primary CD8+ T Cell Response to AST Stimulators in the Presence of IL-2
Stimulator cells
No IL-2 50 U/ml IL-2
Responder Stimulator
cells cells BN LEW p BN LEW p
CD4+ LN 19,799 131 <0.001 25,527 1,672 <0.001
AST 653 492 NS 2,164 1,946 NS
IFN-yAST 534 500 NS 4,670 3,938 NS
C138+ LN 774 63 <0.001 3,460 1,941' 0.05<p<0.1
AST 369 227 NS 16,742 4,414 <0.001
IFN-y AST 247 356 NS 26,373 7,931 <0.001is not as clearly defined as is seen in the absence of llr2 (com-
pare CD8+ T cell response to LN stimulators with and
without I1r2), or indeed in the response of CD4+ T cells
+ Ilr2 which proliferate strongly and specifically toLN stimu-
lators but still show no response toAST . Reducing the amount
of Ilr2, for example to 2 U/ml, resulted in an improvement
in the specificity of the CD8+ T cell response but the level
of proliferation was only around 2 times greater than that
of CD8 + T cells in the absence of exogenous I1r2 . Com-
parable results to these have been obtained withmedium sup-
plemented with either FCS or normal rat serum and when
employing a 10% supernatant of Con A-activated spleno-
cytes as a source of I1r2.
The phenotype of the responding LEW CD8+ T cells in
the presence of IIr2 and BN AST stimulators is shown in
Fig . 8 . A clearly defined minority blast population could be
Figure 8.
￿
Phenotype of responding CD8+ cells in the MLR . LEW
CD8+ T cell/BN AST cultures with added rIL2 comparable to those
described in Table 2 were established and cells recovered after 78-h incuba-
tion . Cells were double labeled with the biotinylated rat antibody, R2/15S
which binds LEW but not BN MHC class I and mouse mAb against
either rat CD8, aag TCR, IL2R, CD45R, CD4 or humanON (con-
trol). R2/15S wasdetected with 10,ug/ml streptavidin-PE and the mouse
mAb with anti-mouse FITC (see Materials and Methods) . Shown is the
green (FITC) channel vs. forward scatter ofthe cells gated to excludeboth
dead cells and R2/15S- cells, the latter being the BN stimulator popu-
lation .
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distinguished (high forward scatter) representing 20-25% of
the total CD8+ T cells at the end of culture . As expected
from the purity of the input cells (Fig . 5), the cells recovered
from culture were exclusively CD8+ and CD4 - . Blasts ap-
peared to express higher amounts ofCD8 than the small cells .
The input cells were around 90% cxo TCR' and the blast
population essentially retained this phenotype. Only the blast
cells expressed the a chain of the IL2R and, significantly,
around two-thirds of the blast cells were CD45RIow while
most small cells retained the CD45Rige phenotype of the
input CD8+ T cells (Fig . 5) .
AST and Secondary Alloreactive CD4+ T Cell Responses .
TheMHC class II-expressingAST used in these experiments
are clearly unable to prime CD4+ T cells, but can they res-
timulate such cells once they have been primed by another
cell type? Preliminary studies to determine ifAST have some
allostimulatory capacity for CD4+ T cells employed a LEW
anti-BN T cell line . The line (designated LEBN-1) was typ-
ical in being CD4+ CD8 - TCRa/0+ . The important
phenotypic changes that distinguish these CD4+ T cells
from those used in the primary MLR studies (Fig. 5) are
illustrated in Fig. 9 . All cells were now completely CD45R
(MRC OX22) negative and IIr2R (ct chain) positive despite
having been rested in 11r2-containing medium in the absence
ofBN stimulator cells, before phenotypic analysis . I1r2R ex-
Figure 9 .
￿
Astrocytes stimulate an alloantigen-specificCD4" T cell line.
(Top panel) Cells from the LEBN-1 (LEW anti-BN) CD4+ T cell line
were rested in 11,2-containing medium then stained for FACScan® anal-
ysis. Dashedline (which overlays the dottedMRC OX21 autofluorescence
plot) isCD45R (MRCOX22 mAb) and the solid lineisIIT2R (cr chain) .
(Bottom panel) 104 resting LEBN-1 cells were added to 5 x 105 LN or
2 x 104 AST stimulator cells fromLEW (/), BN (®) or PVG (m) rats.
Incubation time was 48 h + a 12-h pulse with [ 3H]thymidine. Data are
means of triplicate determinations and are representative of two separate
experiments.pression immediately after stimulation on irradiated BNLN
cells was further enhanced above that shown here, as expected .
Fig. 9 shows that BNAST are indeed capable of specifically
stimulating theLEBN-1 line to proliferate . Reactivity to self
(LEW) or a third party (PVG) is minimal . There was some
response to AST not pretreated withIFN-y as reported pre-
viously employing CD4+ T cell lines specific for CNS au-
toantigens (39) . The response to BN AST is -40% of that
against BN LN cells, the latter being the stimulator popula-
tion that was used to raise the LEBN-11ine . It is not known
why the difference exists but the presence of this positive re-
sponse against AST is nevertheless significant in view of the
previous data with unprimed CD4+ T cells .
Discussion
There has been a significant shift in opinion away from
the concept thatMHC class II expressionon nonhematopoietic
cells may be an important factor in the induction of some
tissue-specific autoimmune diseases. In particular, the evidence
accumulated from transgenic mouse studies involving targeted
MHC expression on elements such as pancreatic a cells have
indicated that such expression alone is not sufficient to induce
an autoimmune inflammation (reviewed in reference 40) . It
has been proposed, but to our knowledge not yet directly
tested, that one reason MHC expression on such cells does
not result in autoimmune inflammation, is because the cells
lack the ability to prime T lymphocyte responses .
The studies reported here are consistent with and further
extend these views in as much as they provide evidence for
the first time thatMHC class II expressionon astrocytes (AST)
which are one of the more thoroughly studied non-
hematopoietic cells exhibiting APC activity, is unlikely to
lead to the induction of an autoreactive T lymphocyte re-
sponse because these MHC-expressing cells are unable to act
as APC for primary T cell responses .
One should qualify this statement to the extent that
CD8+ T cells do appear to be stimulated by AST (Fig. 7)
which is in keeping with previous studies (20, 41) showing
that mouse CD8+ T cells can be triggered by a wider range
ofnon-DC accessory cells than can CD4 + T cells. However,
in the absence of IIr2 (which is predominantly a CD4+ T
cell product, Table 1), CD8+ T cells did not respond to any
substantial degree (Fig . 7 and Table 2) . This virtual depen-
dence of rat CD8+ T cells on CD4+ T cell help confirms
studies from other groups (38, 42) but differs from anumber
of reports (18, 20, 43) in which mouse mouse CD8+ T cells
have been shown to proliferate substantially, to secrete 11,2
and to differentiate into CTL, all in the absence of CD4+
T cells. However, at least in the mouse, this effect appears
to be strain dependent (20) and it is thus unclear to what
extent CD8+ T cell autonomy can be considered a general
phenomenon, particularly in response to nonhematopoietic
stimulator cells. Indeed, recent in vivo studies in mice in-
volving allogeneicMHC class I expression on pancreatic )3
cells (44) and tumour cell rejection in the eye (45), generally
do not support the concept that CD8+ T cells can respond
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effectively to antigen on nonhematopoietic cells in the ab-
sence of CD4+ T cell help.
The response of CD8+ T cells in the present study also
demonstrated two other unusual features after addition of
exogenous 11,2. First, CD8+ T cells, regardless of the
stimulator population (LN or AST) responded to the added
IIT2, at least to some extent, without an apparent require-
ment for specific receptor interaction as evidenced by a high
background proliferation in the presence ofsyngeneic stimu-
lators (see Table 2) . These results are remarkable considering
the essentially IIL2R (a chain) negative condition of the
CD8+ T cells at the initiation of culture (Fig. 5) . NK and
CD8+ but not CD4+ T cells in the human appear to con-
stitutively express the IIr2R (p75) a chain (46) and we are
currently assessing whether this differential expression is also
present in rat T cell subpopulations . Notably, the responding
CD8+ blast cells in our experiments (Fig. 8) were also pre-
dominantly TCR-a/(3+ and not, therefore, NK cells which
are also CD8+ in the rat (37) . The change from high to low
CD45R expression in the blast cell population (Fig. 8) is con-
sistent with previous studies on the CD45R phenotype of
virgin and memoryCD4+ T lymphocytes (47) and has also
been observed on human CD8+ T cells stimulated by al-
logeneic DC (48) . The continuing CD45Rh*6 phenotype of
some of the blast cells (Fig. 8) in these relatively short-term
cultures (78 h) may be due to the slow turnover rate of this
surface molecule (49) .
The second unusual feature of the IIr2-dependent CD8+
T cell response in the present studies was the substantial levels
ofproliferation observed when AST were used as stimulator
cells . Such proliferation indices were never observed using
LN cells as allogeneic stimulators . This may be partly related
to the levels ofMHC class I expressed by the AST (Fig. 2)
but a number of potential stimulators of CD8+ T cells
present in LN (such as DC) are almost certain to express
equivalent or higher levels of this molecule. Alternatively,
the AST may secrete cytokines such as IIT6 (50) to which
the CD8+ T cells respond optimally. It is noteworthy that
even background proliferation in the presence of syngeneic
AST stimulators and IIT2 (Table 2) was higher than when
syngeneic LN stimulators were present (see also Fig. 1) sug-
gesting that AST provided something promoting T cell
growth that LN stimulator cells did not .
Why do unprimed CD4+ T cells not respond to MHC
class II positiveAST stimulator cells? A simple solution would
be that AST are unable to interact with CD4+ T cells but
this is patently not the case given their capacity to restimu-
late already primed alloreactive CD4+ T cells as illustrated
in Fig. 9 . Inadequate levels ofMHC class II may be one ex-
planation, however a low percentage ofAST expressed quite
high levels ofMHC glass II and our system was probably
sensitive enough to detect even a low level of CD4+ T cell
proliferation that resulted from interaction with these AST.
Moreover, in one experiment (not shown) we pretreatedAST
with a combination of human rTNF-a and rat rIFN-y . In
this case, more than60% of BN-strainAST wereMHC class
II positive and the level ofexpression was also increased . Again,
no primary allogeneic CD4+ T cell response was observed.We did not examine this further as TNF-a is known to have
a variety of effects on target cells such as inducing cytokine
release (50) which makes the system somewhat more difficult
to interpret . Possibly, certain cytokines which are required
for priming ofCD4+ T cells may have been absent but ad-
dition of supernatant fromConA-activated splenocytes which,
presumably contained a variety of cytokines in addition to
ID2, did not result in CD4+ T cell priming byMHC class
II positive AST (not shown) . Finally, it is conceivable that
important adhesion molecules were absent either on theAST
or the CD4+ T cells . The AST used here constitutively ex-
press high levels of ICAM-1 which is further enhanced in
the presence ofIFN -'y (E . Kraus, S. Schneider-Schaulies,M .
Miyasaka, and J . Sedgwick, manuscript in preparation), but
other adhesion molecules may be of greater significance .
What do these resultsmean in terms of the induction and
enhancement ofan autoimmune response against tissue-specific
antigens and more specifically, those in the CNS? First, as
there is no evidence from our studies thatMHC Class II ex-
pressing AST can prime CD4+ T cells then it is doubtful
that these cells will initiate an autoreactive T cell response.
However, once the response is initiated by another cell type(s),
not only can the autoreactive T cell induce MHC Class II
expression on the AST (or presumably a range of other non-
hematopoietic cells) via secretion of factors like IFN-y, but
the AST may then restimulate the CD4+ T cell and per-
petuate and enhance the response further. This latter prop-
erty ofAST is certainly not a feature of allMHC class II-ex-
pressing nonhematopoietic cells as, for example, pancreatic
/3 cells (40) and keratinocytes (51) appear to switch off rather
than reactivate already primedT cells. Second, even ifan un-
primed autoreactive CD8+ T cell is activated after interac-
tion with AST, there is also little evidence from our studies
to suggest that any substantial proliferative event would re-
sult unless (CD4+ T cell) help was provided for this cell .
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